Litong Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Litong Yao has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Yingying Xu
Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.
4 shared publications - Mozhi Wang
Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, China
3 shared publications - Jingyi Guo
Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Jianxi, Luoyang, Henan 471003, P.R. China
2 shared publications - Mengshen Wang
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
2 shared publications - Xinyan Li
State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 shared publications - Xueting Yu
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Breast Cancer
- Vol. 26 (2) , 136-151
Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study
Yao L, et al. J Breast Cancer. 2023 Mar;26:e12. https://doi.org/10.4048/jbc.2023.26.e12
- 1 January 2023
- Published by XMLink in Journal of Breast Cancer
- Vol. 26 (2) , 136-151
Open AccessPredicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study
Yao L, et al. J Breast Cancer. 2023 Mar;26:e12. https://doi.org/10.4048/jbc.2023.26.e12
- Open Access
- 14 September 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 134 (5) , 593-595
Body surface area: a new anthropometric measurement for diabetic retinopathy in Chinese adults with type 2 diabetes: a hospital registry case-control study
An abstract is unavailable. This article is available as a PDF only.
- 14 September 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 134 (5) , 593-595
Open AccessBody surface area: a new anthropometric measurement for diabetic retinopathy in Chinese adults with type 2 diabetes: a hospital registry case-control study
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (4) , 410-429
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
Li X, et al. J Breast Cancer. 2019 Nov;23:e45. https://doi.org/10.4048/jbc.2020.23.e45
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (4) , 410-429
Open AccessUpdated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
Li X, et al. J Breast Cancer. 2019 Nov;23:e45. https://doi.org/10.4048/jbc.2020.23.e45
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Breast Cancer
- Vol. 22 (4) , 497-521
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
Li X, et al. J Breast Cancer. 2019 Jul;22:e49. https://doi.org/10.4048/jbc.2019.22.e49
- 1 January 2019
- Published by XMLink in Journal of Breast Cancer
- Vol. 22 (4) , 497-521
Open AccessPredictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
Li X, et al. J Breast Cancer. 2019 Jul;22:e49. https://doi.org/10.4048/jbc.2019.22.e49